TrialBritish journal of clinical pharmacology2017

Pharmacokinetics and pharmacodynamics of PF-05190457: The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects.

William S Denney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.